Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

The Ying-Yang of the virus-host interaction: control of the DNA damage response.

Li R, Hayward SD.

Future Microbiol. 2011 Apr;6(4):379-83. doi: 10.2217/fmb.11.16.

2.

An ATM/Chk2-mediated DNA damage-responsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cells.

Nikitin PA, Yan CM, Forte E, Bocedi A, Tourigny JP, White RE, Allday MJ, Patel A, Dave SS, Kim W, Hu K, Guo J, Tainter D, Rusyn E, Luftig MA.

Cell Host Microbe. 2010 Dec 16;8(6):510-22. doi: 10.1016/j.chom.2010.11.004.

3.

Role of ATM in the formation of the replication compartment during lytic replication of Epstein-Barr virus in nasopharyngeal epithelial cells.

Hau PM, Deng W, Jia L, Yang J, Tsurumi T, Chiang AK, Huen MS, Tsao SW.

J Virol. 2015 Jan;89(1):652-68. doi: 10.1128/JVI.01437-14. Epub 2014 Oct 29.

4.

The importance of epigenetic alterations in the development of epstein-barr virus-related lymphomas.

Takacs M, Segesdi J, Banati F, Koroknai A, Wolf H, Niller HH, Minarovits J.

Mediterr J Hematol Infect Dis. 2009 Nov 15;1(2):e2009012. doi: 10.4084/MJHID.2009.012.

5.

The signaling pathways of Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer.

Pang MF, Lin KW, Peh SC.

Cell Mol Biol Lett. 2009;14(2):222-47. doi: 10.2478/s11658-008-0045-2. Epub 2008 Dec 13. Review.

PMID:
19082921
6.

Epstein-Barr virus-associated lymphoproliferative disorders.

Grywalska E, Markowicz J, Grabarczyk P, Pasiarski M, RoliƄski J.

Postepy Hig Med Dosw (Online). 2013 May 24;67:481-90. Review.

7.

STAT3 interrupts ATR-Chk1 signaling to allow oncovirus-mediated cell proliferation.

Koganti S, Hui-Yuen J, McAllister S, Gardner B, Grasser F, Palendira U, Tangye SG, Freeman AF, Bhaduri-McIntosh S.

Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):4946-51. doi: 10.1073/pnas.1400683111. Epub 2014 Mar 17.

8.

The Epstein Barr nuclear antigen EBNA3C regulates transcription, cell transformation and cell migration.

Subramanian C, Knight JS, Robertson ES.

Front Biosci. 2002 Mar 1;7:d704-16. Review.

PMID:
11861219
9.

The ATM/ATR signaling effector Chk2 is targeted by Epstein-Barr virus nuclear antigen 3C to release the G2/M cell cycle block.

Choudhuri T, Verma SC, Lan K, Murakami M, Robertson ES.

J Virol. 2007 Jun;81(12):6718-30. Epub 2007 Apr 4.

10.

Interplay between DNA tumor viruses and the host DNA damage response.

McFadden K, Luftig MA.

Curr Top Microbiol Immunol. 2013;371:229-57. doi: 10.1007/978-3-642-37765-5_9. Review.

PMID:
23686238
11.

Sodium arsenite induces apoptosis and Epstein-Barr virus reactivation in lymphoblastoid cells.

Zebboudj A, Maroui MA, Dutrieux J, Touil-Boukoffa C, Bourouba M, Chelbi-Alix MK, Nisole S.

Biochimie. 2014 Dec;107 Pt B:247-56. doi: 10.1016/j.biochi.2014.09.002. Epub 2014 Sep 21.

PMID:
25241256
12.

Epstein-Barr virus provides a survival factor to Burkitt's lymphomas.

Kennedy G, Komano J, Sugden B.

Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14269-74. Epub 2003 Nov 5.

13.

E2F1 mediated apoptosis induced by the DNA damage response is blocked by EBV nuclear antigen 3C in lymphoblastoid cells.

Saha A, Lu J, Morizur L, Upadhyay SK, Aj MP, Robertson ES.

PLoS Pathog. 2012;8(3):e1002573. doi: 10.1371/journal.ppat.1002573. Epub 2012 Mar 15.

14.

Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma.

Anderton E, Yee J, Smith P, Crook T, White RE, Allday MJ.

Oncogene. 2008 Jan 17;27(4):421-33. Epub 2007 Jul 23.

PMID:
17653091
15.

Epstein-Barr virus protein can upregulate cyclo-oxygenase-2 expression through association with the suppressor of metastasis Nm23-H1.

Kaul R, Verma SC, Murakami M, Lan K, Choudhuri T, Robertson ES.

J Virol. 2006 Feb;80(3):1321-31.

16.

Epstein-Barr virus infection: basis of malignancy and potential for therapy.

Murray PG, Young LS.

Expert Rev Mol Med. 2001 Nov 15;3(28):1-20.

PMID:
14585152
17.

[Mechanisms of Epstein-Barr Virus-Mediated Oncogenesis].

Iwakiri D.

Gan To Kagaku Ryoho. 2015 Oct;42(10):1133-6. Review. Japanese.

PMID:
26489540
18.

The Epstein-Barr virus and its association with human cancers.

Baumforth KR, Young LS, Flavell KJ, Constandinou C, Murray PG.

Mol Pathol. 1999 Dec;52(6):307-22. Review.

20.

Rapamycin reverses splenomegaly and inhibits tumor development in a transgenic model of Epstein-Barr virus-related Burkitt's lymphoma.

Cen O, Longnecker R.

Mol Cancer Ther. 2011 Apr;10(4):679-86. doi: 10.1158/1535-7163.MCT-10-0833. Epub 2011 Jan 31.

Supplemental Content

Support Center